{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:13:02Z","timestamp":1790435582497,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.jaci.2005.08.050","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T08:44:45Z","timestamp":1130229885000},"page":"1202-1205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Perspectives in asthma: Molecular use of microbial products in asthma prevention and treatment"],"prefix":"10.1016","volume":"116","author":[{"given":"Doina M.","family":"Racila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel N.","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2005.08.050_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2005.08.050_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI21275","article-title":"Inhibition of experimental asthma by indoleamine 2,3-dioxygenase","volume":"114","author":"Hayashi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2005.08.050_bib3","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.160.6.2555","article-title":"Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma","volume":"160","author":"Kline","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2005.08.050_bib4","doi-asserted-by":"crossref","first-page":"L1137","DOI":"10.1152\/ajplung.00073.2003","article-title":"Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure","volume":"285","author":"Jain","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2005.08.050_bib5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0091-6749(99)70022-9","article-title":"CpG oligodeoxynucleotides do not require Th1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma","volume":"104","author":"Kline","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2005.08.050_bib6","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","article-title":"Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells","volume":"173","author":"Moseman","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2005.08.050_bib7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaci.2004.03.003","article-title":"Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA","volume":"113","author":"Simons","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2005.08.050_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaci.2003.11.001","article-title":"Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response","volume":"113","author":"Tulic","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2005.08.050_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1164\/ajrccm.160.1.9808144","article-title":"Variable airway responsiveness to inhaled lipopolysaccharide","volume":"160","author":"Kline","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2005.08.050_bib10","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0140-6736(00)02239-X","article-title":"Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma","volume":"355","author":"Gereda","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2005.08.050_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1067\/mai.2002.125831","article-title":"Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity","volume":"110","author":"Gerhold","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2005.08.050_bib12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20021340","article-title":"Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen","volume":"196","author":"Eisenbarth","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2005.08.050_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2222.2005.02184.x","article-title":"Prenatal lipopolysaccharide-exposure prevents allergic sensitization and airway inflammation, but not airway responsiveness in a murine model of experimental asthma","volume":"35","author":"Blumer","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2005.08.050_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.275.5296.77","article-title":"The inverse association between tuberculin responses and atopic disorder","volume":"275","author":"Shirakawa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jaci.2005.08.050_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.187.4.561","article-title":"Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia","volume":"187","author":"Erb","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2005.08.050_bib16","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4049\/jimmunol.169.3.1492","article-title":"Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation","volume":"169","author":"Zuany-Amorim","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2005.08.050_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm0602-625","article-title":"Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells","volume":"8","author":"Zuany-Amorim","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2005.08.050_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1183\/09031936.03.00042103","article-title":"The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma","volume":"21","author":"Camporota","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2005.08.050_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/intimm\/dxh062","article-title":"Helminth infection modulates the development of allergen-induced airway inflammation","volume":"16","author":"Wohlleben","year":"2004","journal-title":"Int Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674905019408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674905019408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:00:21Z","timestamp":1758776421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674905019408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0091674905019408"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2005.08.050","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives in asthma: Molecular use of microbial products in asthma prevention and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2005.08.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}